CKD-828 (80/5mg) Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Hypertension
Interventions
DRUG

CKD-828

Telmisartan 80mg /S-Amlodipine 5mg(FDC) Tablet, Oral, Once Daily

DRUG

Telmisartan

\- Telmisartan 80mg tablet, Oral, Once Daily (Combination Therapy with S-amlodipine)

DRUG

S-amlodipine

\- S-amlodipine 5mg tablet, Oral, Once Daily (combination Therapy with Telmisartan)

Trial Locations (1)

700-721

Kyungpook National University Hospital, Daegu, Samdeok-dong, 2-ga 50

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02250833 - CKD-828 (80/5mg) Pharmacokinetic Study | Biotech Hunter | Biotech Hunter